Amgen Inc. lost requests for several judgments in Lindis Biotech GmbH’s patent-infringement lawsuit seeking damages for sales of the leukemia treatment Blincyto, according to a federal judge’s mixed ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the ...

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

Wolfe Research has recently initiated Amgen Inc (AMGN) stock to Peer Perform rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 14, 2024, Citigroup had initiated the ...

Senior Gwen Eichfeld, captain of the Colgate University women’s ice hockey team, goes above and beyond in her role as a ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BMO Capital analyst Evan Seigerman has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

Novartis forecasts delayed blood-cancer drug launches while Amgen anticipates crucial weight-loss drug data. Additionally, Neuralink has advanced its brain chip trials in Canada. Political dynamics ...

Lowering BMI alone may reduce the risk of various obesity-related diseases, but other factors might also play a role. A new ...